Jui Dutta

895 total citations
14 papers, 752 citations indexed

About

Jui Dutta is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jui Dutta has authored 14 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jui Dutta's work include NF-κB Signaling Pathways (4 papers), Cell death mechanisms and regulation (3 papers) and interferon and immune responses (2 papers). Jui Dutta is often cited by papers focused on NF-κB Signaling Pathways (4 papers), Cell death mechanisms and regulation (3 papers) and interferon and immune responses (2 papers). Jui Dutta collaborates with scholars based in United States, Bangladesh and India. Jui Dutta's co-authors include Céline Gélinas, Gaofeng Fan, Nupur Gupta, Ying Fan, Yongjun Fan, Hiroshi Yasui, Mei Zheng, Kumar Sukhdeo, Haiying He and Constantine Mitsiades and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Jui Dutta

11 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jui Dutta United States 8 461 215 183 172 66 14 752
Jue Yang China 18 557 1.2× 269 1.3× 203 1.1× 131 0.8× 42 0.6× 60 933
Aida S. Hansen Denmark 10 509 1.1× 184 0.9× 247 1.3× 172 1.0× 41 0.6× 21 903
Hui-Wen Cheng Taiwan 18 523 1.1× 290 1.3× 192 1.0× 161 0.9× 24 0.4× 27 929
Parijat Senapati India 15 611 1.3× 244 1.1× 139 0.8× 102 0.6× 29 0.4× 28 861
Yiqing Zhao China 16 628 1.4× 125 0.6× 196 1.1× 173 1.0× 28 0.4× 37 901
Tomoko Inoue Japan 19 565 1.2× 200 0.9× 286 1.6× 175 1.0× 48 0.7× 50 1.0k
Mark A. Pattoli United States 10 411 0.9× 368 1.7× 230 1.3× 296 1.7× 52 0.8× 14 891
Sheri L. Bonar United States 13 455 1.0× 263 1.2× 152 0.8× 262 1.5× 33 0.5× 15 763
Davide Vecchiotti Italy 12 347 0.8× 214 1.0× 103 0.6× 121 0.7× 24 0.4× 27 609

Countries citing papers authored by Jui Dutta

Since Specialization
Citations

This map shows the geographic impact of Jui Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui Dutta more than expected).

Fields of papers citing papers by Jui Dutta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui Dutta. The network helps show where Jui Dutta may publish in the future.

Co-authorship network of co-authors of Jui Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Jui Dutta. A scholar is included among the top collaborators of Jui Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui Dutta. Jui Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Dutta, Jui, et al.. (2022). A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus. 14(9). e29657–e29657. 15 indexed citations
3.
Dutta, Jui, et al.. (2022). Role of Prophylactic Steroids in Differentiation Syndrome. Cureus. 14(9). e29531–e29531.
4.
Dutta, Jui, et al.. (2022). Fournier’s Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy. Cureus. 14(8). e27773–e27773. 14 indexed citations
5.
Dutta, Jui, et al.. (2022). Rapid Turn From Cirrhosis to Encephalopathy Following COVID-19 Infection: A Cautionary Tale. Cureus. 14(2). e22089–e22089. 1 indexed citations
7.
Fan, Yongjun, Jui Dutta, Nupur Gupta, & Céline Gélinas. (2013). Molecular Basis of Oncogenesis by NF-κB: From a Bird's Eye View to a RELevant Role in Cancer.
8.
Mani, Mala, Jui Dutta, Yunyu Zhang, et al.. (2008). The BCL9 Oncogene Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic and Angiogenic Properties to Myeloma Cells. Blood. 112(11). 648–648. 1 indexed citations
9.
Dutta, Jui, Gaofeng Fan, & Céline Gélinas. (2008). CAPERα Is a Novel Rel-TAD-Interacting Factor That Inhibits Lymphocyte Transformation by the Potent Rel/NF-κB Oncoprotein v-Rel. Journal of Virology. 82(21). 10792–10802. 38 indexed citations
10.
Fan, Yongjun, Jui Dutta, Nupur Gupta, Gaofeng Fan, & Céline Gélinas. (2007). Regulation of Programmed Cell Death by NF-κB and its Role in Tumorigenesis and Therapy. Advances in experimental medicine and biology. 615. 223–250. 121 indexed citations
11.
Sukhdeo, Kumar, Mala Mani, Yunyu Zhang, et al.. (2007). Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proceedings of the National Academy of Sciences. 104(18). 7516–7521. 184 indexed citations
12.
Dutta, Jui, Ying Fan, Nupur Gupta, Gaofeng Fan, & Céline Gélinas. (2006). Current insights into the regulation of programmed cell death by NF-κB. Oncogene. 25(51). 6800–6816. 349 indexed citations
13.
Ghosh, Utpal, Bhaswati Pandit, Jui Dutta, & Nitai P. Bhattacharyya. (2004). Induction of apoptosis by benzamide and its inhibition by aurin tricarboxylic acid (ATA) in Chinese hamster V79 cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 554(1-2). 121–129. 10 indexed citations
14.
Pandit, Bhaswati, et al.. (2001). Co-amplification of dhfr and a homologue of hmsh3 in a Chinese hamster methotrexate-resistant cell line correlates with resistance to a range of chemotherapeutic drugs. Cancer Chemotherapy and Pharmacology. 48(4). 312–318. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026